NEWS
Institutional Subscription: Comprehensive Analyses to Enhance Your Global and Local Impact
New Feature: Compare Your Institution with the Previous Year
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Find a Professional
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Rebecca S Cook
Vanderbilt University - Nashville / United States
Natural Sciences / Molecular Biology & Genetics
AD Scientific Index ID: 1346119
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Rebecca S Cook's MOST POPULAR ARTICLES
1-)
Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastasesRS Muraoka, N Dumont, CA Ritter, TC Dugger, DM Brantley, J Chen, ...The Journal of clinical investigation 109 (12), 1551-1559, 20026612002
2-)
TGF-β inhibition enhances chemotherapy action against triple-negative breast cancerNE Bhola, JM Balko, TC Dugger, MG Kuba, V Sánchez, M Sanders, ...The Journal of clinical investigation 123 (3), 1348-1358, 20135582013
3-)
Molecular profiling of the residual disease of triple-negative breast cancers after neoadjuvant chemotherapy identifies actionable therapeutic targetsJM Balko, JM Giltnane, K Wang, LJ Schwarz, CD Young, RS Cook, ...Cancer discovery 4 (2), 232-245, 20145032014
4-)
RAS/MAPK activation is associated with reduced tumor-infiltrating lymphocytes in triple-negative breast cancer: therapeutic cooperation between MEK and PD-1/PD-L1 immune …S Loi, S Dushyanthen, PA Beavis, R Salgado, C Denkert, P Savas, ...Clinical Cancer Research 22 (6), 1499-1509, 20165592016
5-)
Transcriptional and posttranslational up-regulation of HER3 (ErbB3) compensates for inhibition of the HER2 tyrosine kinaseJT Garrett, MG Olivares, C Rinehart, ND Granja-Ingram, V Sánchez, ...Proceedings of the National Academy of Sciences 108 (12), 5021-5026, 20115242011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept